The development, validation, and implementation of non-animal tests for quality control of vaccines require a coordinated dialogue and collaboration between the different stakeholders.

The VAC2VAC consortium includes twenty organisations from eight different countries including all relevant stakeholders:

VAC2VAC facilitates efficient partnership whereby all members provide scientific, technical and regulatory know-how, with the aim of ensuring the successful development of innovative non-animal methods and the implementation of the consistency approach for vaccine quality control.